News and events archive

Paper from Selbo’s project group featured on the cover of Photochemical & Photobiological Sciences

The paper entitled “Enhanced targeting of triple-negative breast carcinoma and malignant melanoma by photochemical internalization of CSPG4-targeting immunotoxins” by Marius S. Eng et al. was a joint academic-industry effort including collaboration with the Ferronel lab at Massachusetts General Hospital/Harvard Medical School, the Rosenblum lab at MD Anderson Cancer Center, the Mælandsmo lab at Oslo University Hospital (OUS), the Imaging Facility at the Institute for Cancer Research (OUS) and PCI Biotech. The manuscript was published in the May issue of Photochemical & Photobiological Sciences (The Royal Society of Chemistry), which is a society-owned journal publishing high quality research on all aspects of photochemistry and photobiology.

 

Award ceremony May 25thOslo University Hospital awards 6 excellent articles for the second half-year of 2017

From the award ceremony May 25th

In order to stimulate excellent research and draw attention to the hospital's extensive research activity, Oslo University Hospital reward outstanding publications regularly.

Six research groups were awarded for their excellent papers published during the second half-year of 2017 on May 25th in the large auditorium at Ullevål sykehus. Each group received NOK 50.000 for use in further research. The prize winners gave short presentations of the main findings in their respective articles.

 

Gut bacteria flora linked to chronic heart failure

Martin Kummen (left) and Marius Trøseid

Findings from scientists at the Research Institute of Internal Medicine published in the prestigious "Journal of the American College of Cardiology" (journal impact factor 19.9) has received attention.  Martin Kummen and Marius Trøseid are first and last authors on the publication, entitled "Gut Microbiota Signature in Heart Failure Defined From Profiling of 2 Independent Cohorts".

The Norwegian popular science web site "forskning.no" has recently written about the results, and interviewed senior author Marius Trøseid about the linking of gut bacteria flora to chronic heart failure.

 

Theodossiou and Berg presented in national media after receiving prestigious EU grant

Berg and Theodossiou with Prime Minister Erna Solberg and Minister of Research and Higher Education Iselin Nybø. Photo: Hallgeir Vågenes/ VG

Theodossis Theodossiou and Kristian Berg from the Photochemical internalisation (PCI) group at the Department of Radiation Biology at the Institute for Cancer Research have been funded by the Future and Emerging Technology (FET) program under the Excellent Science section of the Horizon 2020. The FET program funded 11 projects out of 820 grant applications (1,4 % success rate) and the proposal by Theodossiou and Berg was rated as number 6. The  project is designed to develop treatment of aggressive brain tumors such as glioblastoma multiforme (GBM).
The major national newspaper VG recently (May 3rd) published a feature article about the supported project, entitled "Pioneering Norwegian technology: aiming to kill aggressive brain tumors by producing light in the brain."

 

Oslo Myeloma Center in the media

Fredrik Schjesvold has recently been interviewed for NRK's "Ekko".

Fredrik Schjesvold, leader of the "Oslo Myeloma Center" research group at the Department of Haematology at Oslo University Hospital, has recently been interviewed by the national broadcasting corporation NRK for the the popular radio programme "Ekko", under the column "Meet a researcher". Schjesvold has also been interviewed for an international multiple myeloma podcast. Furthermore, a video presenting the Oslo Myeloma Center has been produced.

 

OUS research blog article:Treating rare bleeding disease with cancer medicine

Johan Steineger (left) and Sinan Dheyauldeen

In a recent OUS research blog article Johan Steineger and Sinan Dheyauldeen from the Department for Otorhinolaryngology, Head and Neck Surgery explain how they came to treating patients with Morbus Osler - a rare autosomal dominant disorder that affects blood vessels throughout the body (causing vascular dysplasia) and results in a tendency for bleeding. - with the anti-angiogenic medicine Avastin, which is often used with chemotherapy to prevent tumor growth.

 

Espen Melum "Researcher of the Month"

Espen Melum

Espen Melum, head of the "Experimental Hepatology" group at the Research Institute of Internal Medicine, under the Division of Surgery, Inflammatory Diseases and Transplantation, was appointed "Researcher of the Month" for March 2018 by the South-Eastern Norway Regional Health Authority (Helse Sør-Øst RHF).
Melum's research group studies why inflammation occurs in the bile ducts, which in turn can lead to liver failure. His work is presented in a feature article published on the home page of Helse Sør-Øst.

 

OUH research seminar, Monday, April 16th, 2018, at 14:30 – 16:00Precision medicine in complex diseases

Welcome to the next Oslo University Hospital (OUH) research seminar entitled
Precision medicine in complex diseases

Time: Monday, April 16th, 2018, at 14:30 – 16:00
Place: Red Auditorium, Rikshospitalet, Sognsvannsveien 20, Oslo

Speakers: Yvonne Böttcher, Hanne Flinstad Harbo, Torbjørn Omland, Kåre I. Birkeland, Rune A. Høglund.

 

 

European Research Council Advanced Grant to Stenmark for the second time

Professor Harald Stenmark. Foto: Øystein Horgmo, UiO

Professor Harald Stenmark, head of the "Cellular membrane dynamics" group at the Department of Molecular Cell Biology, receives ERC Advanced Grant for the second time. Only two other Norwegian researchers, Professor Edvard Moser (NTNU) and Professor Kenneth Hugdahl (UiB), have received ERC Advanced Grant twice in their careers.

The research project "Coincidence detection of proteins and lipids in regulation of cellular membrane dynamics (CODE)" will last for five years and has been awarded 2.5 million Euro.

 

Mini symposium Cancer Genomics, April 17th, 10am-4pmOn the occasion of King Olav V's award to Professor Vessela N. Kristensen

On the occasion of King Olav V's award 2018 to professor Vessela N. Kristensen there will be held a mini symposium  on cancer genomics April 17th at 10am-4pm in the Auditorium at the Institute for Cancer Research, in the K building at Montebello.
Speakers are prominent scientists Olga Troyanskaya, Charles Vaske, Sampsa Hautanemi, Diether Lambrechts, Gyan Bhanot, Peter Fasching and Zohar Yakhini.

 

 

Cancer study led by OUH scientists presented by major national newspaper VG

From left: Ree, Mælandsmo and Flatmark. (photo: Gøran Bohlin, VG)

The national newspaper VG (Norway's largest news source) presented a research project led by Anne Hansen Ree, Gunhild Mælandsmo, Hege Russnes and Kjersti Flatmark in a comprehensive feature article published on April 2nd, entitled (translated to) "Norwegian researchers with a new breakthrough: Special treatment provides hope for cancer patients".

 

Novel subtype-specific prognostic associations of KRAS and BRAF mutations revealed in colorectal cancer

First author Jørgen Smeby with co-author Ina A. Eilertsen

In a recent publication in Annals of Oncology (journal impact factor 11.9) by Jørgen Smeby and colleagues in the Lothe lab at the Department of Molecular Oncology, integration of gene expression-based subtyping and microsatellite instability status led to discovery of novel subtype-specific prognostic associations of the thoroughly investigated KRAS and BRAFV600E mutations in primary colorectal cancer (CRC).

 

Prestigious neurological award to David Russell

David Russell (photo: Øystein Horgmo)

Professor David Russell has received the prestigious Monrad-Krohns Prize for 2018 for his research contributions on diagnosis and treatment of stroke. 
"It is a great honor for me and a very important recognition of Norwegian research in cerebrovascular diseases," says the award winner, who is professor at UiO, and senior physician at the Department of Neurology at Oslo University Hospital, where he is heading the "Cerebrovascular diseases" research group.

 

Jon Amund Kyte "Researcher of the Month"

Jon Amund Kyte (photo: Elin B. Øvrebø)

Jon Amund Kyte, leader of the "Translational cancer immunotherapy" project group at the Department of Cancer Immunology at the Institute for Cancer Research, was appointed "Researcher of the Month" for February 2018 by the South-Eastern Norway Regional Health Authority (Helse Sør-Øst RHF). 
The group aims to develop improved cancer treatment based on two particularly promising strategies for immunotherapy. This research is presented in a feature article published on the home page of Helse Sør-Øst.

 

International Women's day, March 8th 2018:The Challenges women face in pursuing a career in STEM (science/technology/engineering/mathematics)

Guro E. Lind (photo: Terje Heiestad)
Global Engage has interviewed Guro E. Lind, group leader at the Department of Molecular Oncology.
 
"In order to achieve gender balance we should focus on why the system is failing recruiting the brilliant young female scientists, rather than discuss what the females should do to increase their chances of a scientific career. It is nothing wrong with our education, skill set or ambitions - it is the system that is flawed"    
 
 

Updated:King Olav V´s Cancer Research Prize for 2018 to Vessela Kristensen

Vessela Kristensen (Photo: Nicki Twang)

King Olav V's cancer research award for 2018 went to professor Vessela Kristensen, head of the Cancer Genome Variation Group at the Department of Cancer Genetics at the Institute for Cancer Research.

The prestigious prize was handed over by HM Kong Harald V on behalf of the Norwegian Cancer Society in Oslo on April 16th. 

New: The Norwegian Cancer Society has recently published a feature article about Vessela Kristensen and her research.

 

OUH research seminar, Monday, March 5th, 2018, at 14:30 – 16:00Tissue engineering and regenerative medicine

Welcome to the next Oslo University Hospital (OUH) research seminar entitled
Tissue engineering and regenerative medicine

Time: Monday, March 5th, 2018, 14:30 – 16:00
Place: Red Auditorium, Rikshospitalet, Sognsvannsveien 20, Oslo

Speakers: Joel Glover, Kamal Babikeir Eln Mustafa, Shadab Abadpour, Rick Siller

 

 

Nature Communications publication:A human endothelial cell-based recycling assay for screening of FcRn targeted molecules

The HERA-team. Larger photo and caption under "More"

In a study published in Nature Communications on February 12th, establishment of a novel in vitro cellular assay is reported, which can be used to gain in-depth insights into how antibodies and albumin variants are transported in and out of cells, and to predict how efficiently such molecules are rescued from intracellular degradation. The assay has been coined HERA and stands for human endothelial cell-based recycling assay.

The study is based on research conducted by scientists from the Laboratory of Adaptive Immunity and Homeostasis, headed by Jan Terje Andersen, at OUH and UiO, together with several international collaborators from Harvard Medical School, The Jackson Laboratory and Roche Pharma Research and Early Development in Munich.

 

Kyrre Emblem among the three research talents honoured by the Norwegian Research Council

Kyrre Eeg Emblem

One of The Norwegian Research Council's three new prizes for young outstanding researchers goes to Kyrre Eeg Emblem from the Department of Diagnostic Physics at the Division of Radiology and Nuclear Medicine. Each prize is 500.000 kroner and will be distributed on March 1st.

Kyrre Eeg Emblem's research will benefit cancer patients directly. Using MRI machines, he can predict how different therapies work on people with cancer. The goal is to understand how the treatment affects the disease, and thereby predict which patients respond to the cancer treatment.

 

Ole Jacob Elle appointed "Innovator of the Month" by "Helse Sør-Øst"

Ole Jacob Elle

Ole Jacob Elle, head of the "Medical Robotics, visualisation and navigation" research group at The Intervention Centre at the Divsion of Emergencies and Critical Care has been selected as "Innovator of the Month" by the South-Eastern Norway Regional Health Authority (Helse Sør-Øst RHF). 
Elle's research activities and interests are presented in a popular science article (in Norwegian) entitled "Technology and health - hand in hand". He is fascinated by robots, holograms and navigation systems, and how these things can make everyday life in health care better.

 
Previous news articles
 Substantial grant from HELSEVEL to Jon Michael Gran  
 Leiv Arne Rosseland "Researcher of the Month" for January 2018  
 Interdepartmental collaboration cuts drug costs on expensive antibodies for treating eye diseases  
 Prestigious grant to Tor Erik Rusten  
 New developments in gynecologic oncology OUH research seminar, Monday, February 5th, 2018, at 14:30 – 16:00 
 Karl-Johan Malmberg interviewed by NRK on the potential of killer cell research in cancer treatment  
 Therese Sørlie appointed "Scientist of the Month" by "Helse Sør-Øst"  
 Rusten group research project on cell organisation and tumor growth highlighted by the Norwegian Cancer Society  
 Excellent Researcher Award and Early Career Award 2018 Nominating outstanding scientists, closing date March 1st: 
 Genetics of cardiovascular diseases OUH research seminar, Monday, January 15th, 2018, at 14:30 – 16:00 
 Tillotts Pharma AG signs license agreement on antibody technology developed by OUS and UiO scientists Press release Jan 22, 2018
 Cell therapy research presented in national newspaper VG  
 Preclinical drug screening identifies novel stratified treatment options according to the consensus molecular subtypes of colorectal cancer  
 The discovery of TIGIT as a potential new target for immune checkpoint blockade is published in Clinical Cancer Research.  
 Scientists from the Research Institute of Internal Medicine receive funding from ERA-Net  
 Oslo University Hospital has awarded 6 excellent articles for the first half-year of 2017  
 Per Steinar Halvorsen appointed "Innovator of the Month" by Helse Sør-Øst  
 The challenges of discovering new antibiotics OUH research seminar, Monday, December 4th 14:30 
 The Laboratory of Adaptive Immunity and Homeostasis enters a strategic research collaboration with a leading pharmaceutical company Press release – 29 Nov 2017 
 Alicia Llorente participates in an ERA-NET funded project  
 Young Investigator Prize to Anita Sveen during annual "Onkologisk Forum" meeting Nov 2017  
 Michael Bretthauer appointed "Scientist of the Month" by "Helse Sør-Øst"  
 Paper on novel pathway selected for inclusion in the ‘In This Issue’ section of Journal of Cell Science  
 Jan Terje Andersen receives a grant of 8.5 million NOK from NANO2021  
 Professor Kjetil Taskén is presented as new director of the Department of Cancer Research at the Cancer Clinic, Oslo University Hospital  
 Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors Nature Communications publication: 
 A study of the epigenetics of breast cancer provides clues to mechanisms behind subtypes of the disease Nature Communications publication: 
 Maria Torgersen receives a grant of 8.5 million NOK from NANO2021  
 Inequality in genetic cancer risk: Bad genes or bad luck? Nature Communications article from OCBE: 
 Rusten group uncovers new regulatory mechanism of the Peutz-Jeghers cancer syndrome kinase, LKB1 Update: Nature Cell Biology paper attracts interest: 
 Major study of genetics of breast cancer provides clues to mechanisms behind the disease CNN coverage: 
 Albumedix has signed research agreement with OUS and UiO on CIR research  
 CCB researchers uncover novel mechanism of cellular metabolic control  
 New additional treatment for breast cancer patients Breast cancer research highlighted by the Norwegian Cancer Society: 
 Individualized cancer treatment OUH research seminar, Monday, October 9th 14:30 
 Induced pluripotent stem cell research featured on Norwegian national news broadcast  
 Tor Inge Tønnessen "Researcher of the Month" for September  
 Collaboration to identify novel biomarkers that can predict whether a patient will respond positively to pembrolizumab  
 Scientific opportunities in Europe Sept 29th - Information day about EMBL, EMBO and HSPF: 
 Jahre lecture Thursday September 14th  
 The Norwegian Cancer symposium 2017 on Precision Medicine Scandic Holmenkollen Park, December 4-6, 2017: 
 Anne-Lise Børresen-Dale appointed Commander of the Royal Norwegian St. Olavs Order  
 ERC Starting Grant 2017 to Kyrre Eeg Emblem  
 Tone Rustøen "Researcher of the Month" for July  
 Håvard Danielsen appointed "Scientist of the Month" by "Helse Sør-Øst" for June 2017  
 OUH scientists involved in sequencing study of osteosarcoma that has identified mutations in IGF signalling genes  
 Øyvind S. Bruland appointed "Innovator of the Month" by Helse Sør-Øst  
 Lars Tjelta Westlye appointed "Scientist of the Month" by "Helse Sør-Øst" for May 2017  
  Annuncement of research funding from South-East Norway regional health authority for 2018 Call for applications 2018 
 Oslo University Hospital has awarded 6 excellent articles for the second half-year of 2016  
 Clinically important genetic heterogeneity in colorectal cancers with microsatellite instability  
 Per O. Seglen awarded King Olav V's cancer research prize for 2017  
 New mechanism for rare skin disorder discovered  
 Norwegian research with international impact Less expensive medicine results in treatment for more patients 
 The 2017 Excellent Research Awards to Kirsten Sandvig, Johannes Espolin Roksund Hov and Tor Paaske Utheim  
 Organ donation for abdominal and thoracic organs OUH research seminar, Monday, May 8th 14:30 - 16:00 
 Placing my research in an H2020 project Program Info - workshops held May 8-9th: 
 New insight into late effects after cancer treatment presented by the Norwegian Cancer Society  
 Immunotherapy for Cancer OUH research seminar, Tuesday, April 25th 10:00 - 15:45 
 Study on replication fork stability from Skarstad group published in Nucleic Acids Research  
 Innovation to Finance Research OUH research seminar, Monday, April 3rd 14:30 
 NORMENT researchers contribute to PLOS Medicine article on genetic assessment of age-associated Alzheimer's disease risk  
 The AACR-WICR Friend Lectureship presented to Anne-Lise Børresen-Dale  
 CanCell – a new Centre of Excellence – will reprogram cancer cells  
 Jørgen Wesche appointed group leader for the Mesenchymal Cancer Biology Group at the Department of Tumor Biology New group leader at the Institute for Cancer Research: 
 Prestigious research prize from the Norwegian Cancer Society to pioneer in autophagy research King Olav V´s Cancer Research Prize to Per O. Seglen Mar 7, 2017
 Health after transplantation OUH research seminar, Monday, March 6th 14:30 
 Early signs of mental illness in the developing brain NORMENT study published in Nature Neuroscience: 
 Arne Klungland talks about embryo research Breakfast lecture in Oslo Wednesday March 1st: 
 Thon Awards seminars 2017 Invitation to seminar March 2nd 12:00 
 Critical article on doping and drug testing published in EMBO reports  
 Early phase drug development: From idea to concept OUH research seminar, Monday, February 6th 14:30 
 "Science" article from Johanna Olweus's group highlighted by editorial in New England Journal of Medicine  
 6th National Conference on Stroke Oslo Kongressenter, February 09-10 2017 
 Theis Tønnessen appointed "Scientist of the Month" by "Helse Sør-Øst" for January 2017  
 Sepsis: New definitions and future research OUH research seminar, Thursday, January 26th 
 Excellent Researcher Award and Early Career Award 2017 Announcement: Nominating outstanding scientists, closing date March 1st: 
 Antimicrobial resistance - how bad is the situation in the world of virus, fungus and mycoplasma? OUH research seminar, Monday, January 16th 
 Findings from Rusten group published in Nature on microenvironmental autophagy draw nationwide attention Updated: honoured with "Preview" article in Developmental Cell  
 Commentary article from Arne Klungland in Nature Methods on epitranscriptome analysis  
 Research funding from South-Eastern Norway Regional Health Authority for 2017  
 Educating future cancer researchers from Ullern high school  
 Novel cancer immunotherapy published in Cancer Research, with cover illustration  
 Oslo University Hospital has awarded 6 excellent articles for the first half-year of 2016  
 Oslo University Hospital research seminar: Exercise and Brain Energy Monday, November 21st, 2016, at 14:30 – 16:10 
 Oslo University Hospital research seminar: The World of Immunology Thursday November 17th at 10:00-15:00 
 Oslo University Hospital researchers receive 77.3 mill NOK from the Norwegian Cancer Society Results of Open Call 2016: 
 Human lung macrophages are self-maintained for several years  
 Announcement of research funding from the Norwegian Cancer Society Gathering Friday October 28th 10-12 at UiO: 
 Dag Berild awarded the "Akademikerprisen" for his work on antibiotic resistance  
 50 years anniversary Institute for Surgical Research Thursday 13 October 2016 at 10.15 AM 
 Making therapeutic antibodies from scratch  
 Lina Prasmickaite's work presented in popularised form  
 Medical imaging in cardiac research Oslo University Hospital research seminar Monday October 10th 
 Focus on personalized medicine and the MetAction study  
 Histone marks regulate maternal-to-zygotic transition Paper from Dahl/Klungland published in the Sep 22nd issue of Nature 
 Turning the tide of antimicrobial resistance National kick-off, Tuesday September 13th 
 Marina Vietri interviewed for major Italian research web portal  
 OUH researchers publish groundbreaking computer tools for cell biology research in Nature Methods  
 POLE proofreading domain mutations identify a subset of immunogenic colorectal cancers with excellent prognosis  
Page visits: 2164